Emergent BioSolutions (EBS) Operating Income (2011 - 2026)
Emergent BioSolutions (EBS) posted Operating Income of -$125.1 million for Q2 2026, down 1291.43% on a QoQ basis from $10.5 million in Q1 2026, and down 7918.75% year-over-year from $1.6 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Operating Income (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported Operating Income for 16 years, with the latest figure at -$125.1 million in Q2 2026.
- On a quarterly basis, Operating Income fell 7918.75% year-over-year to -$125.1 million in Q2 2026; TTM through Jun 2026 was -$66.0 million, a 161.97% decrease from a year earlier, with the FY2025 full-year figure at $100.1 million, up 192.09% from the prior year.
- Operating Income was -$125.1 million for Q2 2026 at Emergent BioSolutions, down from $10.5 million in the prior quarter.
- The five-year high for Operating Income was $76.5 million in Q3 2025, with the low at -$292.9 million in Q2 2023.
- Average Operating Income over 5 years is -$56.6 million, with a median of -$35.8 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Operating Income surged 126.96% in 2024, then slumped 7918.75% in 2026.
- Over 5 years, Operating Income stood at -$55.3 million in 2022, then climbed by 20.8% to -$43.8 million in 2023, then jumped by 78.31% to -$9.5 million in 2024, then tumbled by 193.68% to -$27.9 million in 2025, then sank by 348.39% to -$125.1 million in 2026.
- The last three Operating Income figures came in at -$125.1 million (Q2 2026), $10.5 million (Q1 2026), and -$27.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 360.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | 1.22 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 325.05 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | -505.13 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | -125.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -125.10 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | -27.90 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 49.90 Mn |
| Dec 31, 2024 | -9.50 Mn |
| Sep 30, 2024 | 64.50 Mn |
| Jun 30, 2024 | -203.50 Mn |
| Mar 31, 2024 | 39.80 Mn |
| Dec 31, 2023 | -43.80 Mn |
| Sep 30, 2023 | -242.10 Mn |
| Jun 30, 2023 | -292.90 Mn |
| Mar 31, 2023 | -147.60 Mn |
| Dec 31, 2022 | -55.30 Mn |
| Sep 30, 2022 | -45.30 Mn |
| Jun 30, 2022 | -76.30 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 286.80 Mn |
| Sep 30, 2021 | -44.70 Mn |
API Access
Emergent BioSolutions Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();